BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26652907)

  • 1. Optimal therapy for resectable rectal cancer.
    Thavaneswaran S; Price TJ
    Expert Rev Anticancer Ther; 2016; 16(3):285-302. PubMed ID: 26652907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia.
    Hildebrandt B; Wust P; Gellermann J; Nicolaou A; Trappe RU; Felix R; Riess H; Rau B
    Onkologie; 2004 Oct; 27(5):506-11. PubMed ID: 15585984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary treatment of resectable rectal cancer.
    Ayala DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer.
    Mannaerts GH; Schijven MP; Hendrikx A; Martijn H; Rutten HJ; Wiggers T
    Eur J Surg Oncol; 2001 Apr; 27(3):265-72. PubMed ID: 11373103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for resectable rectal and colonic cancer.
    Heriot AG; Kumar D
    Br J Surg; 1998 Mar; 85(3):300-9. PubMed ID: 9529480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
    McGartland LP; Mulcahy MF; Benson AB
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):806-14. PubMed ID: 16166957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
    Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
    Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rectal cancer: current status of multimodal therapy--when and how?].
    Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
    Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of combined-modality therapy in the management of locally advanced rectal cancer.
    Hosein PJ; Rocha-Lima CM
    Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal cancer radiotherapy.
    Ramsey S; Tepper JE
    Cancer J; 2007; 13(3):204-9. PubMed ID: 17620771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do t3 rectal cancers always need radiochemotherapy?
    Glynne-Jones R
    Recent Results Cancer Res; 2014; 203():95-115. PubMed ID: 25103002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy for locally recurrent rectal cancer.
    Moriya Y
    Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality management of locally advanced rectal cancer.
    Moore HG; Guillem JG
    Am Surg; 2003 Jul; 69(7):612-9. PubMed ID: 12889627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome.
    Mezhir JJ; Shia J; Riedel E; Temple LK; Nash GM; Weiser MR; Paty PB; Wong WD; Guillem JG
    Ann Surg; 2012 Aug; 256(2):274-9. PubMed ID: 22791103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the health-related quality of life and sexual functioning of patients with rectal cancer: does type of treatment matter?
    Traa MJ; Orsini RG; Den Oudsten BL; De Vries J; Roukema JA; Bosman SJ; Dudink RL; Rutten HJ
    Int J Cancer; 2014 Feb; 134(4):979-87. PubMed ID: 23934989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer.
    Bikhchandani J; Ong GK; Dozois EJ; Mathis KL
    Dis Colon Rectum; 2015 Mar; 58(3):283-7. PubMed ID: 25664705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment for locally advanced rectal carcinoma.
    Pasetto LM; Pucciarelli S; Agostini M; Rossi E; Monfardini S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):61-71. PubMed ID: 15363467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of chemoradiotherapy for the treatment of rectal cancer].
    Koda K; Miyazaki M
    Gan To Kagaku Ryoho; 2002 May; 29(5):703-8. PubMed ID: 12040673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
    MacGregor TP; Maughan TS; Sharma RA
    J Clin Pathol; 2012 Oct; 65(10):867-71. PubMed ID: 22734005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.